Devices & Diagnostics Why Abbott Believes Its New Pacemaker Will Help It Capture More Market Share By Katie Adams
Devices & Diagnostics Abbott-Bigfoot Deal Proves That Diabetes Is a Hot Area for Digital Health Investment By Katie Adams
Devices & Diagnostics Recent Abbott Snafu Shines Spotlight on Social Media’s Role in Public Health Crisis Response By Katie Adams
Devices & Diagnostics Abbott’s HeartMate 3 extends life by 5 years for advanced heart failure patients By Marissa Plescia
Devices & Diagnostics, Consumer / Employer Abbott is out to win hearts and minds. Will it one day become a household name? By Arundhati Parmar
News, Devices & Diagnostics, Payers Abbott seeks expanded indication, national coverage for CardioMEMS device By Elise Reuter
Devices & Diagnostics Abbott takes on competition with FDA approval of device to prevent afib-related strokes By Elise Reuter
Devices & Diagnostics, Telemedicine FDA approval brings remote programming for Abbott’s deep brain stimulation device By Arundhati Parmar
Diagnostics As problems grow with Abbott’s fast Covid test, FDA standards are under fire By Rachana Pradhan, Kaiser Health News
Diagnostics, Devices & Diagnostics Abbott’s rapid Covid-19 test poses safety issues for lab workers By Rachana Pradhan, Kaiser Health News
Diagnostics Report: Pathologist says Abbott’s rapid Covid-19 test produces 15% false-negative rate By Alaric DeArment
Daily, Diagnostics Abbott gets emergency use authorization for rapid Covid-19 test By Alaric DeArment
